Pharmacokinetics
last authored:
last reviewed:
Introduction
Pharmacokinetics describes the concentrations of drug in the body over time
Mathematical representation is used to describe absorption, distribution, metabolism, and excretion
Related to effects of drugs on the body, or pharmacodynamics
Information is used to perform dosage calculations
Absorption
- requires passage across biological membranes
- majority of oral absorption occurs in the duodenum (large SA)
- affected by GI motility, blood flow (conc. gradient)metabolism and efflux, pH
passive diffusion
- most common
- rate depends on concentration, size, polarity, ionization
active transport
- not common
- requires energy and proteins; saturable
- effective for highly polar molecules (ie vitamin C)
return to top
Bioavailability
Bioavailability is affected by the route of administration and must be factored into dose calculations
Major factors affecting bioavailability with oral drugs include:
- nature of drug formuation (stabilizers, binders, etc)
- chemical properties of drugs affecting absorption
- efflux from enterocytes
- first-pass metabolism in liver and intestine
return to top
Drug Distribution
Reversible movement from blood to body tissues
Extent depends on:
- blood flow to given tissue
- ability of drug to transverse biological membranes
- degree of binding to blood proteins
Volume of Distribution
- apparent volume of fluid in which a drug is distributed
- assumes equal partioning throughout body; ie plasma concentration = that of rest of body
- as Vd remains contstant for a given drug, dose can be calculated to acheive a desired concentration
Vd = Q / Cp
- Vd = volume of distribution
- Q = total amount of drug in body
- Cp = plasma concentration
A large Vd implies retention in tissues outside of plasma, while a small Vd implies primary plasma retention
Some tissues have more/less affinity for a given agent
Binding to plasma proteins such as albumin reduces the amount of drug available, but acts as a reservoir
return to top
Metabolism
metabolism of any given drug can vary up to 50-fold in a population, based on:
- diet and environment (ie smoking)
- genetic factors
- age
- sex
- disease
Phase I metabolism
- creating or unmasking of small polar/reactive groups, ie -OH, -SH, -NH2
- cytochrome P450 (CYP) families 1,2,3responsible
- broad substrate range; low individual specificity
- expression varies amongst individuals
- can be induced or inhibited by drugs and diet compounds
- most common cause of ADRs
Phase II metabolism
conjugation of larger polar groups to small reactive functional groups, ie glucuronic acid, sulfate, glutathione, acetate
return to top
Excretion
Elinimation half-life is independent of dose
Kidney is most important route for drug and metabolites, with active secretion taking place
- most water and lipophilic molecules are reabsorbed inloop of Henle
- polar compunds are not!
- pH of urine can affect reabsorption
Liver: bile
Other:sweat, tears, reproductive fluids, milk, lung
return to top
Clearance
- rate of elimination through metabolism and excretion
- t 1/2 = (0.693 x Vd) / Cl
return to top